Skip to main content

School and University

    Students and Apprentices

    Undergraduate and PhD Students

    Teachers

    Higher Education Statistics

    Scholarships

Career

    Career Guidance

    Job Vacancies

    Salary Information and Income Survey

    Academy

    Mentoring

Community

    Divisions

    Young Chemists’ Forum (JCF)

    Local Sections

    Regulars' Get-Togethers

    Chem_Connect

    Equal Opportunities and Diversity

    Partnerships and International Activities

    Volunteering

    Membership

Discover Chemistry

    Top Topics

    “Nachrichten aus der Chemie” – Members’ Magazine

    Scientific Journals

    Statements and Position Papers

    Press Releases

    Brochures and Academic Publications

    Books, Videos and Podcasts

    The Fascination of Chemistry

    Cartoons

    Biographies of Female Chemists

Events

    Conferences

    Academy

    Lectures

    Further Events

Awards

    Prices

    Historical Sites of Chemistry

About Us

    Board and Other Bodies

    The Office

    Statutes and Code of Conduct

    Charities

    Press and Public Relations

    Sustainability

MyGDCh

GDCh

Chemistry for a better world

© 2026 Gesellschaft Deutscher Chemiker. All rights reserved.

NewsletterDownloadsPressContactGDCh Shop
Legal NoticeData PrivacyTerms & Conditions
Homepage/Divisions/Medicinal Chemistry/Board
Medicinal Chemistry

Board

Board

Board of the GDCh Division of Medicinal Chemistry

2023–2026

Dr. Gerhard Heßler (Chair), Sanofi-Aventis Deutschland, Frankfurt a.M.

Dr. Tatjana Ross (Deputy Chair), Merck KGaA, Darmstadt

Prof. Dr. Christian Ducho, Saarland University, Saarbrücken

Prof. Dr. Anna Hirsch, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken

Dr. Christian Kuttruff, Boehringer Ingelheim International GmbH, Biberach

Prof. Dr. Holger Stark, Heinrich Heine University Düsseldorf


Permanent guest of the Executive Board
Dr. Philipp Barbie, Bayer AG, Berlin (NextGenMedChem representative)

Dr. Franz von Nussbaum (Chair), Nuvisan ICB GmbH, Berlin
Prof. Dr. Anna Hirsch (Deputy Chair), Helmholtz Institute for Pharmaceutical Research (HIPS), Saarbrücken
Dr. Horst Dollinger, Schemmerhofen
Prof. Dr. Christian Ducho, Saarland University, Saarbrücken
Dr. Gerhard Heßler, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main
Prof. Dr. Stefan Laufer, University of Tübingen